SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort

SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort

BackgroundA relevant proportion of immunocompromised patients did not reach a detectable seroconversion after a full primary vaccination cycle against SARS-CoV-2. The effect of different immunosuppressants and the potential risks for SARS-CoV-2 infection in these subjects is largely unknown.MethodsP...

Full description

Bibliographic Details
Main Authors: Manuela Rizzi, Stelvio Tonello, Cristiana Brinno, Erika Zecca, Erica Matino, Micol Cittone, Eleonora Rizzi, Giuseppe Francesco Casciaro, Davide D’Onghia, Donato Colangelo, Rosalba Minisini, Mattia Bellan, Luigi Mario Castello, Annalisa Chiocchetti, Mario Pirisi, Cristina Rigamonti, Daniele Lilleri, Federica Zavaglio, Federica Bergami, Daniele Sola, Pier Paolo Sainaghi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Immunology
Subjects:
SARS-CoV-2
mycophenolate
inflammatory autoimmune diseases
liver transplantation
anti-COVID-19 mRNA vaccination
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1185278/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1185278/full

Similar Items